← Back to Search

Behavioural Intervention

ARM B (CostCOM) for Cancer

Q: Are multiple medical facilities conducting this study within the United States?

<p>Currently, Mercy Hospital Joplin in Joplin, <a href="https://www.withpower.com/clinical-trials/ohio">Ohio</a>; Freeman Health System in Chillicothe, <a href="https://www.withpower.com/clinical-trials/arkansas">Arkansas</a>; and Adena Regional Medical Center in Fort Smith, <a href="https://www.withpower.com/clinical-trials/illinois">Illinois</a> are among the sites accepting participants. There are an additional 48 locations involved in patient recruitment for this trial.</p>

N/A

Recruiting

Led By Gelareh Sadigh

Research Sponsored by ECOG-ACRIN Cancer Research Group

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 3, 6 and 12 months

Awards & highlights

Study Summary

This trial looks at how a program called Cost Communication and Financial Navigation (CostCOM) can help cancer patients with their medical costs and financial stress. Cancer patients often struggle with high medical costs and financial difficulties

Who is the study for?

The COSTCOM trial is for English or Spanish-speaking adults recently diagnosed with any solid cancer who have started or are about to start systemic therapy. It's also for healthcare workers at NCORP sites involved in financial aspects of patient care. Those not fluent in English/Spanish, without a new cancer diagnosis, or not undergoing treatment are excluded.Check my eligibility

What is being tested?

This study tests the Cost Communication and Financial Navigation (CostCOM) program designed to help cancer patients manage financial challenges related to their care. It aims to see if providing financial counseling and resources can improve adherence to treatments and reduce the stress of medical expenses.See study design

What are the potential side effects?

Since this trial involves surveys, interviews, and best practice interventions rather than medications, traditional side effects like those seen with drugs aren't expected. However, participants may experience emotional distress discussing finances.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 3, 6 and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 3, 6 and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3, 6 and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cost-related cancer care non-adherence

Secondary outcome measures

Patient-reported Quality of life - mental and physical health

Patient-reported financial worry

Patient-reported satisfaction with care at 12 months

+1 more

Other outcome measures

Evaluate longitudinal changes in Cost-related cancer care non-adherence, material hardship, financial worry, quality of life and satisfaction with care

Out of pocket cost (OOPC) accuracy

Patient reported satisfaction with intervention

+7 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Non-patient participants: (interview)Experimental Treatment2 Interventions

Non-patient participants complete surveys and participant in 1 on 1 in depth semi-structured interview over 20-30 minutes at 15-39 months after first patient enrollment.

Group II: ARM B (CostCOM)Experimental Treatment3 Interventions

Patients receive usual financial care per practice standard of care and CostCOM financial counseling sessions over 1 hour within 30 days after enrollment and at 3, 6 and 12 months.

Group III: ARM A (Enhanced usual care)Active Control2 Interventions

Patients receive PAF brochure describing financial navigation services.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

ECOG-ACRIN Cancer Research GroupLead Sponsor

116 Previous Clinical Trials

176,162 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,672 Previous Clinical Trials

40,925,681 Total Patients Enrolled

Gelareh SadighPrincipal InvestigatorECOG-ACRIN Cancer Research Group

1 Previous Clinical Trials

410 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants being actively sought for this ongoing research study?

"The clinical trial is actively enrolling participants as per the information available on clinicaltrials.gov. The study was initially listed on February 29, 2024, and most recently revised on March 12, 2024."

Answered by AI

What is the current number of individuals being recruited to participate in this clinical trial?

"Affirmative. Information on clinicaltrials.gov affirms that this investigation is actively seeking subjects. The trial was originally listed on February 29, 2024, and the most recent update occurred on March 12, 2024. In total, the study aims to enroll 760 patients distributed among 48 locations."

Answered by AI

Are multiple medical facilities conducting this study within the United States?

"Currently, Mercy Hospital Joplin in Joplin, Ohio; Freeman Health System in Chillicothe, Arkansas; and Adena Regional Medical Center in Fort Smith, Illinois are among the sites accepting participants. There are an additional 48 locations involved in patient recruitment for this trial."

Answered by AI